EUVIMEDEUVIMED entdecken
Crossref

Change in the neutrophil‐lymphocyte ratio may predict early recurrence in operated bladder cancer

Rumeysa Çolak, Gökmen Umut Erdem, Caner Kapar, İlkay Gültürk, Faruk Aksu, Gülçin Şahingöz Erdal, Mesut Yılmaz, Deniz Tural iD

Asia-Pacific Journal of Clinical Oncology · 2025

DOI: 10.1111/ajco.14065 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Asia-Pacific Journal of Clinical Oncology, 2025. Verfasst von Rumeysa Çolak und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Neutrophils, Lymphocytes, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Recurrence develops in 50% of operated bladder cancer patients. It is important to detect recurrence in advance, and there is no prognostic reliable biomarker for bladder cancer.

Objective

The aim of this study is to show that changes in hematological parameters before radiological imaging can predict recurrence.

Methods

We performed a retrospective cohort study of patients undergoing radical cystectomy for urothelial carcinoma of the bladder identified using our institutional database (2010–2022). Disease‐free survival (DFS) was evaluated as relapse or death due to any cause. Kaplan‐Meier analysis was used for DFS according to the follow‐up period. DFS was calculated in two groups neutrophil‐lymphocyte ratio (NLR) < 3 and NLR ≥ 3. Log‐rank test was used for comparison between groups and p < 0.05 was considered statistically significant.

Results

In the study, 91 patients were examined. The median age was 61.0 (34–79). 57.1% of the patients were T (1–2) and 42.9% were T (3–4). The lymph node (LN) was negative in 78% and positive in 22%. Median follow‐up time and DFS were 53.4 months and 54%, respectively. The median NLR was 2.8 (0.8–8.7). For DFS, there was a significant difference according to age, T stage, and LN status (p: 0.048, 0.019, and 0.040). There was no significant difference in the NLR in terms of DFS at the time of diagnosis (p: 0.654). In follow‐ups; While there was no difference in the NLR for DFS 12 months before recurrence (p: 0.231), there was a significant difference 6 months before the relapse and at the time of recurrence (p: 0.023 and 0.031).

Conclusion

The change in the NLR before radiological recurrence in bladder cancer is significant in predicting recurrence. Prospective and multi‐center research is needed to confirm our findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsNeutrophilsLymphocytesNeoplasm Recurrence, LocalHumansMaleFemaleMiddle AgedRetrospective StudiesAgedAdultPrognosis

Stichwörter der Autor:innen

bladder cancerdisease‐free survivalneutrophil‐lymphocyte ratiorecurrenceurothelial carcinoma

Autor:innen und Institutionen

  • Department of Medical Oncology, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey.
  • Department of Medical Oncology, Başakşehir Çam and Sakura City Hospital, Istanbul, Turkey.

ORCID-Profile: Deniz Tural

Zitieren

APA

Çolak, R., Erdem, G. U., Kapar, C., Gültürk, İ., Aksu, F., Erdal, G. Ş., Yılmaz, M., & Tural, D. (2025). Change in the neutrophil‐lymphocyte ratio may predict early recurrence in operated bladder cancer. Asia-Pacific Journal of Clinical Oncology. https://doi.org/10.1111/ajco.14065

Vancouver

Çolak R, Erdem GU, Kapar C, Gültürk İ, Aksu F, Erdal GŞ, et al. Change in the neutrophil‐lymphocyte ratio may predict early recurrence in operated bladder cancer. Asia-Pacific Journal of Clinical Oncology. 2025. doi:10.1111/ajco.14065

BibTeX
@article{olak2025,
  author = {Çolak, Rumeysa and Erdem, Gökmen Umut and Kapar, Caner and Gültürk, İlkay and Aksu, Faruk and Erdal, Gülçin Şahingöz and Yılmaz, Mesut and Tural, Deniz},
  title = {Change in the neutrophil‐lymphocyte ratio may predict early recurrence in operated bladder cancer},
  journal = {Asia-Pacific Journal of Clinical Oncology},
  year = {2025},
  doi = {10.1111/ajco.14065}
}
Kostenlos starten →